DoAI Inc. was established in March 2018 in Korea and the United States aiming for the world best practice. One of our greatest strengths is by having a strategic partnership with medical institutions and hospitals at local and abroad.

We are creating a service that can apply massive medical data to clinically applicable data using AI by machine learning AI engineers, Data Scientists, Genetic scientists, and software engineers Our business field focuses on AI-based image analysis solutions / Integrated analysis solutions through pathology and Multi-omics data / Early diagnosis and companion diagnosis analysis solutions